Science & Research

Nanotechnology Guidance Documents

FDA has issued several guidance documents on topics relating to the application of nanotechnology in FDA-regulated products.   These guidance documents are being issued as part of FDA's ongoing implementation of recommendations from FDA's 2007 Nanotechnology Task Force ReportWhile guidance documents do not create or confer any rights for or on any person and do not operate to bind FDA or the public, they do represent FDA's current thinking on a topic.  The following guidance documents discuss the use of nanotechnology or nanomaterials in FDA-regulated products:

Final Guidance

Draft Guidance

For more information about FDA guidance documents, click here.

 

Page Last Updated: 03/23/2018
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English